Original document(14 pages)  中文版
    A process for configuring multi-type, high-titer, high-abundance and high-diversity antibody libraries and antigen libraries in procaryotic cell and eukaryotic cell is disclosed, which features use of procaryotic and eukaryotic cell reproduction expression. Its screening features that according to the DNA sequence of antigen epitope gene, the all or part of the open reading frames for antigen gene and the special protein coding gene are combined to form fusion gene for screening the high-specificity and-affinity antibody.
Application Number
申请号
01145721 Application Date
申请日
2001.12.30
Title 名称 Scaled procaryotic cell and eucaryotic cell internal antibody and antigen library construction and screening
Publication Number
公开号
1429916 Publication Date
公开日
2003.07.16
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C12Q1/68,G01N33/569,G01N33/68
Applicant(s) Name
申请人
Han Zeguang
Address 地址 201203
Inventor(s) Name 发明人 Han Zeguang, Liu Feng
Attorney & Agent 代理人 chen zhiliang
More information 更  多  信  息


 Related patents information
New human hydroxybutyryl coenzyme A dehydratase protein and its coding sequence
New human protein and its coding sequence
Human oxide-reductase protein and its coding sequence
Human adenosine-diphosphate ribosyglucose hydrolase protein and its coding sequence
New human triphosphatase protein and its code sequence
Diene cryl coenzyme reductase as one new kind of human peroxidase and its code sequence
Human membrane translocator and its coding sequence
Precursor heteromorphic protein of human calcium binding protein and its coding sequence
Human carboxypeptidase precursor protein and its coding sequence
New human zinc-finger protein and its code sequence
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.